Real Nutriceutical Group Ltd. – Glaucus Research

Real Nutriceutical Group Limited (2010.HK) (“Real Nutri” or the “Company”) produces and sells nutritional supplements and health drinks, primarily amino acid-based tablets and liquids. In this report we present publicly available evidence, including PRC government filings, tax rankings, and the results of retail channel checks, which in our opinion, indicate that Real Nutri’s sales and net income are substantially less than reported to investors and regulators in the Company’s Hong Kong filings. We believe that much like China Medical Technologies (NASDAQ: CMEDY) and China Lumena (HK: 0067), Real Nutri’s equity is worth HKD 0.00 and trading of its stock should be halted to protect future investors from further losses and hopefully provide a modicum of recovery for creditors.